Alford DP, Liebschutz J & Chen IA. (2008). Update in pain medicine. Journal of General Internal Medicine. 23(6), 841-5.
American Medical Director Association. (2009). Pain Management in the Long-term Care Setting. American Medical Directors Association: Columbia MD.
America Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-V), 5th ed., America Psychiatric Association, Washington.
Anxiety and Depression Association of America. (2013). Facts & Statistics. Retrieved October 1, 2014.
Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT & Oslin DW. (2009). The association between chronic pain and prescription drug abuse in Veterans. Pain Medicine. 10(3), 531-6.
Becker WC, Fiellin DA & Desai RA. (2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: psychiatric and socio-demographic correlates. Drug and Alcohol Dependence. 90(2-3), 280-7.
Bogle KE & Smith BH. (2009). Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Current Drug Abuse Review. 2(2), 157-76.
Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard PM Gerhard DS & Stewart WF. (2010). Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 105(10), 1776-82.
Boscarino JA, Rukstalis M, Hoffman SN, Han JJ, Erlich PM, Gerhard GS & Stweard WF. (2010). Risk factors for drug dependence among outpatients on opioid therapy in a large U. S. healthcare system. Addiction. 105(10), 1776-82.
Brown ME, Swiggar WH, Dewey CM & Ghulyan MV (2012). Searching for answers: proper prescribing of controlled prescription drugs. Journal of Psychoactive Drugs. 44(1), 79-85.
Center for Disease Control. (2014). Opioid Painkiller Prescribing. Retrieved October 1, 2014.
Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain. 10(2),113-30.
CLOOS JM & FERREIRA V. (2009). CURRENT USE OF BENZODIAZEPINES IN ANXIETY DISORDERS. CURRENT OPINIONS IN PSYCHIATRY. 22(1), 9095.
Closs SJ & Briggs M. (2002). Patients' verbal descriptions of pain and discomfort following orthopaedic surgery. International Journal of Nursing Studies. 39(5), 563-72.
Colburn JL, Jasinski DR & Rastegar DA. (2012). Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic. Journal of Opioid Management. 8(3), 153-60.
Department of Veteran Affairs and Department of Defense. Tapering and Discontinuing Opioids. Retrieved October 11, 2014.
Drug Enforcement Agency. (2014). Controlled Substance List. Retrieved October 12, 2014.
Edlund MJ, Steffick D, Hudson T, Harris KM & Sullivan M (2007). Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain. 129(3), 355-62.
National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. JAMA. 280(22),1936-43.
Franklin G. (2014). Opioids for chronic noncancer pain. Neurology. 83(14), 1277-1284.
Fredman S & Korn M. (2002). Anxiety Disorders and Related Conditions. Retrieved October 1, 2014 from Medscape.
Gwira-Baumbladd JA, Weideman C, Dunn JR, Schaffner W, Paulozzi LJ & Jones TF. (2014). High-risk use by patients prescribed opioids for pain and its role in overdose deaths. JAMA Internal Medicine. 174(5), 796-801.
Hall AJ, Logan JE, Toblin RL, Hall AJ, Kaplan JA, Kraner JC, Bixler D, Crosby AE & Paulozzi LJ. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 300(22), 2613-20.
Hardt J, Jacobsen C & Goldberg J. (2008). Prevalence of chronic pain in a representative sample in the United States. Pain Medicine. 9(7), 803-12.
Healthy People 2010. DATA 2010. 2014. Retrieved October 1, 2014 from the Center For Disease Control.
Institute of Medicine. (2011). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Retrieved October 1, 2014.
Jones CM, Mack KA & Paulozzi LJ. (2013). Pharmaceutical overdose deaths, United States, 2010. JAMA. 309(7), 657-9.
Kaye S & Darke S. (2012). The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care? Addiction. 107(3), 467-77.
Kuehn BM. (2007). Prescription drug abuse rises globally. Journal of the American Medical Association. 297(12), 1306.
Lewis M, Herndon CM & Chibnall JT. (2012). Patient aberrant drug taking behaviors in a large family medicine residency program: a retrospective chart review of screening practices, incidence, and predictors. Journal of Opioid Management. 10(3),169-75.
Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Bourne E, Cabral H & Samet JH (2010). Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. The Journal of Pain. 11(11), 1047-55.
Lorenz KA, Sherbourne CD, & Shugarman LR (2009). How reliable is pain as the fifth vital sign? Journal of the American Board of Family Medicine. 22(3), 291-8.
MANCHIKANTI L, ABDI S, ATLURI S, BALOG CC, BENYAMIN RM, BOSWELL MV, BROWN KR, BRUEL BM, BRYCE DA, BURKS PA, BURTON AW, CALODNEY AK, CARAWAY DL, CASH KA, CHRISTO PJ, DAMRON KS, DATTA S, DEER TR, DIWAN S, ERIATOR I, FALCO FJ, FELLOWS B, GEFFERT S, GHARIBO CG, GLASER SE, GRIDER JS, HAMEED H, HAMEED M, HANSEN H, HARNED ME, HAYEK SM, HELM S, HIRSCH JA, JANATA JW, KAYE AD, KAYE AM, KLOTH DS, KOYYALAGUNTA D, LEE M, MALLA Y, MANCHIKANTI KN, MCMANUS CD, PAMPATI V, PARR AT, PASUPULETI R, PATEL VB, SEHGAL N, SILVERMAN SM, SINGH V, SMITH HS, SNOOK LT, SOLANKI DR, TRACY DH, VALLEJO R, WARGO BW; AMERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS. (2012). MERICAN SOCIETY OF INTERVENTIONAL PAIN PHYSICIANS (ASIPP) GUIDELINES FOR RESPONSIBLE OPIOID PRESCRIBING IN CHRONIC NON-CANCER PAIN: PART 2--GUIDANCE. PAIN PHYSICIAN. 15(3 SUPPL), S67-116.
Martell BA, O'Connor PG, & Kerns RD. (2007). Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Annals of Internal Medicine. 146(2), 116-27.
Merikangas KR & McClair VL. (2012). Epidemiology of substance use disorders. Human Genetics. 131(6), 779-89.
Merskey H & Bogduk N. (1994). Classification of Chronic Pain, 2nd ed. IASP Press: Seattle.
National Centers for Health Statistics. (2006). Chartbook on Trends in the Health of Americans 2006. Special feature: pain. Retrieved October 1, 2014 from the Center for Disease Control.
Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, DiCapua P & Chou R. (2014). Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Annals of Internal Medicine. 160(1), 38-47.
Otto MW & Pollack MH. (2009). Stopping Anxiety Medication. 2nd Edition. Oxford University Press: Oxford, UK.
SAMHSA. (2012). Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713. Rockville, MD.
Sehgal N, Manchikanti L & Smith HS. (2012). Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 15(3 Suppl), ES67-92.
Sehgal N, Manchikanti L & Smith HS. (2012). Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 15(3 Suppl), ES67-92.
Seitz DP. (2005). Screening mnemonic for generalized anxiety disorder. Canadian Family Physician. 51(10), 1340-1342.
Sofeff S. (2014). Attention Deficit Hyperactivity Disorder. Retrieved October 17, 2014 from Medscape.
Spiller HA, Hays HL & Aleguas A Jr. (2013). Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 27(7), 531-43.
Stewart WF, Ricci JA, & Chee E. (2003). Lost productive time and cost due to common pain conditions in the US workforce. Journal of the American Medical Association. 290, 2443-54.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2013). The TEDS Report: 2001-2011: National Admissions to Substance Abuse Treatment Services. Retrieved October 3, 2014.
Tcheremissine OV & Salazar JO. (2008). Pharmacotherapy of adult attention deficit/hyperactivity disorder: review of evidence-based practices and future directions. Expert Opinion in Pharmacotherapy. 9(8), 1299-310.
Turk DC, Wilson HD & Cahana A. (2011). Treatment of chronic non-cancer pain. Lancet. 377(9784), 2226-35.
Volkow ND & Swanson JM. (2008). Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? American Journal of Psychiatry. 165(5), 553-5.
Webb JR, Valasek MA & North CS. (2013). Prevalence of stimulant use in a sample of US medical students. Annals of Clinical Psychiatry. 25(1), 27-32.
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L & Fusillo S. (2008). Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry. 47(1), 21-31.
WORLD HEALTH ORGANIZATION. WHO'S PAIN LADDER. RETRIEVED OCTOBER 1, 2014.